全文获取类型
收费全文 | 89675篇 |
免费 | 9715篇 |
国内免费 | 6095篇 |
专业分类
耳鼻咽喉 | 869篇 |
儿科学 | 1174篇 |
妇产科学 | 596篇 |
基础医学 | 7489篇 |
口腔科学 | 2169篇 |
临床医学 | 11581篇 |
内科学 | 9639篇 |
皮肤病学 | 1114篇 |
神经病学 | 2982篇 |
特种医学 | 3701篇 |
外国民族医学 | 28篇 |
外科学 | 9229篇 |
综合类 | 21612篇 |
现状与发展 | 29篇 |
一般理论 | 6篇 |
预防医学 | 8342篇 |
眼科学 | 1769篇 |
药学 | 10161篇 |
136篇 | |
中国医学 | 7274篇 |
肿瘤学 | 5585篇 |
出版年
2024年 | 378篇 |
2023年 | 1245篇 |
2022年 | 3589篇 |
2021年 | 4600篇 |
2020年 | 3875篇 |
2019年 | 2580篇 |
2018年 | 2639篇 |
2017年 | 3098篇 |
2016年 | 2592篇 |
2015年 | 4208篇 |
2014年 | 5355篇 |
2013年 | 5812篇 |
2012年 | 8420篇 |
2011年 | 8949篇 |
2010年 | 7042篇 |
2009年 | 6092篇 |
2008年 | 6580篇 |
2007年 | 5916篇 |
2006年 | 5276篇 |
2005年 | 4228篇 |
2004年 | 2892篇 |
2003年 | 2369篇 |
2002年 | 1904篇 |
2001年 | 1570篇 |
2000年 | 1395篇 |
1999年 | 782篇 |
1998年 | 354篇 |
1997年 | 328篇 |
1996年 | 269篇 |
1995年 | 224篇 |
1994年 | 169篇 |
1993年 | 130篇 |
1992年 | 105篇 |
1991年 | 94篇 |
1990年 | 93篇 |
1989年 | 69篇 |
1988年 | 51篇 |
1987年 | 60篇 |
1986年 | 46篇 |
1985年 | 32篇 |
1984年 | 9篇 |
1983年 | 10篇 |
1982年 | 12篇 |
1981年 | 8篇 |
1980年 | 4篇 |
1979年 | 6篇 |
1978年 | 5篇 |
1976年 | 4篇 |
1975年 | 4篇 |
1926年 | 2篇 |
排序方式: 共有10000条查询结果,搜索用时 281 毫秒
1.
2.
Bortezomib is a novel proteasome inhibitor, which has been successfully used to treat mantle cell lymphoma and multiple myeloma. However, the direct effects of bortezomib on acute promyelocytic leukaemia (APL) have not been fully investigated. In the present study, the WST-8 assay, western blotting, flow cytometry, monodansylcadaverine staining and transmission electron microscopy were performed. It was demonstrated that bortezomib treatment induced a time- and dose-dependent decrease in the viability of NB4 cells. Bortezomib treatment induced cell apoptosis in NB4 cells, as assessed by Annexin V/propidium iodide analysis, and the detection of cleaved caspase-3, cleaved poly(ADP-ribose) polymerase, Bax and Bcl-2 expression. Furthermore, bortezomib treatment induced autophagy in NB4 cells, as indicated by autophagosome formation, p62 degradation, LC3-I to LC3-II conversion and formation of acidic autophagic vacuoles. Notably, autophagy induced by bortezomib was initiated prior to apoptosis. Inhibition of autophagy by knocking down Beclin-1 expression increased bortezomib-induced apoptosis in NB4 cells. Therefore, the present study revealed that the combination of bortezomib and autophagy inhibition may be a potential treatment strategy for APL. 相似文献
4.
Lei Yang You-Ling Shi Yan Ma Wei-Wei Ren Guang-Ming Pang Jiao Liu 《APMIS : acta pathologica, microbiologica, et immunologica Scandinavica》2022,130(1):43-52
Krüppel-like factor 16 (KLF16), a member of the Krüppel-like factor (KLF) family, has been extensively investigated in multiple cancer types. However, the role of KLF16 in oral squamous cell carcinoma (OSCC) remains unknown. Thus, we conducted this study to investigate its related mechanism. KLF16 expression in OSCC cell lines was quantified by western blotting. Then, OECM1 and OC3 cells were divided into Blank, siCtrl, siKLF16#1 and siKLF16#2 groups. Subsequently, cell proliferation was detected using 3-[4,5-dimethylthiazol-2-yl]-2,5 diphenyl tetrazolium bromide (MTT) assays, cell migration and invasion were detected with wound healing and Transwell assays, and cell cycle distribution and cell apoptosis were detected via flow cytometry. KLF16, p21, CDK4, Cyclin D1 and p-Rb expression was detected by western blotting. Finally, xenograft models were established in nude mice to observe the in vivo effects of KLF16 on OSCC. KLF16 protein expression was upregulated in OSCC cells. Compared to the cells in the Blank group, the OECM1 and OC3 cells in the siKLF16#1 group and siKLF16#2 group exhibited a sharp decrease in proliferation but a remarkable increase in apoptosis. Moreover, the proportion of cells in the G0/G1 phase notably increased and that in the S phase decreased, with evident decreases in cell invasion and migration. Moreover, KLF16, cyclin-dependent kinase 4 (CDK4), Cyclin D1 and p-Rb protein expression was upregulated, but p21 expression was downregulated. The mice in the siKLF16#1 and siKLF16#2 xenograft model groups exhibited slower tumour growth and smaller tumours with evident downregulation of Ki67 expression compared to the mice in the Blank group. KLF16 expression was upregulated in OSCC cells, and interfering with KLF16 led to cell cycle arrest, inhibited OSCC cell growth and promoted cell apoptosis. 相似文献
5.
6.
目的探讨品管圈在植入式静脉输液港(IVAP)患者护理中的应用。方法选取本院2018年10月-2018年12月IVAP患者30例作为对照组,2019年1月-2019年3月品管圈活动干预后IVAP患者30例作为观察组。对照组采用常规护理措施,观察组采用品管圈活动干预后的护理措施。比较两组IVAP患者并发症的发生率和对护理工作的满意度。结果观察组导管堵塞1例;并发症发生率为3.33%(1/30)。对照组感染4例,血栓2例,导管堵塞4例;并发症发生率为33.33%(10/30)。观察组并发症发生率低于对照组(P <0.05)。观察组对优质服务、技术水平、关怀、出院指导、护理总满意度评分分别为(42.39±5.27)分、(31.49±4.32)分、(22.25±4.69)分、(20.26±4.91)分、(112.24±10.38)分;对照组分别为(38.65±4.91)分、(28.68±4.26)分、(19.96±4.30)分、(19.94±4.63)分、(103.37±10.12)分;观察组对优质服务、技术水平、关怀、出院指导、护理总满意度评分均高于对照组(P <0.05)。结论通过品管圈活动干预后的护理措施明显降低IVAP患者并发症的发生率,提高患者对护理工作的满意度。 相似文献
7.
8.
9.
目的:探讨保留肾脏的输尿管部分切除术治疗原发性输尿管癌的长期疗效。方法:回顾性分析1999年3月~2013年2月行保留肾脏的输尿管部分切除术的31例输尿管癌患者临床资料:12例患者行输尿管膀胱再植术,19例行输尿管端端吻合术。随访14~171个月,观察术后尿路肿瘤复发率、患者总体生存率、肿瘤分期及病理分级方面分层生存率等情况。结果:术后尿路肿瘤复发率为19.35%(6/31);总体5年及10年生存率分别为77.41%、58.64%;低肿瘤分期组5年及10年生存率均为86.67%,高肿瘤分期组5年及10年生存率分别为74.93%和54.29%;低病理分级组5年及10年生存率均为76.00%,高病理分级组5年及10年生存率分别为78.26%和48.83%。结论:在严密随访下,输尿管部分切除术可以有效治疗低分期、低分级输尿管癌。 相似文献